Q32 Bio Inc. (QTTB)
NASDAQ·Healthcare·Biotechnology
$5.79
+5.85%
Mkt Cap $65.58M
Analyst Ratings
No recent rating data.
Price Target (8 analysts)
$13.00
Range $13.00 – $13.00
Implied Upside
+124.5%
Consensus $13.00 vs current $5.79
NASDAQ·Healthcare·Biotechnology
$5.79
+5.85%
Mkt Cap $65.58M
No recent rating data.
Price Target (8 analysts)
$13.00
Range $13.00 – $13.00
+124.5%
Consensus $13.00 vs current $5.79